ceralifimod
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2010 (NCT01081782)
Timeline
2010s
- Jan 1, 2010
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
S1PR5 agonist
S1PR1 agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ceralifimod
- ono-4641
- ono-4641
- ono-4641
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01226745 | Phase 2 | Oct 1, 2010 | Merck KGaA, Merck Serono, Ono Pharmaceuticals |
| NCT01081782 | Phase 2 | Mar 1, 2010 | Ono Pharmaceuticals |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Ono Pharmaceuticals | For profit | 2 | 1 | 1 | 2010 |
| Merck KGaA | For profit | 1 | 0 | 1 | 2010 |
| Merck Serono | For profit | 1 | 1 | 1 | 2010 |
3 organizations
Page 1 / 1